Furthermore, we validated HMGCS2 as a tumor suppressor in renal clear cell carcinoma (ccRCC) through in vitro experiments, demonstrating that the loss of HMGCS2 leads to malignant cellular behavior in ccRCC. Here, HMGCS2 is linked to nonpapillary renal cell carcinoma.